Testosterone does decline with age, but the story is less tidy than many adverts suggest. A lower result can reflect ageing, illness, sleep disruption, obesity, medication, pituitary or testicular disease, or simply a badly timed blood test. Lifestyle can help some men, especially when metabolic health is part of the picture. It is not a substitute for diagnosis when symptoms and repeated low measurements point to hypogonadism.
Start with the measurement, not the myth
The first problem with testosterone decline is that the number is easy to overread. Testosterone follows a daily rhythm, tends to be highest in the morning, and varies from test to test. A single borderline result, particularly if it was taken late in the day or during illness, is not enough to explain fatigue, low mood, poor training, weight gain, or reduced libido.
The Endocrine Society’s 2018 clinical practice guideline is deliberately strict on this point: clinicians should diagnose hypogonadism only when symptoms or signs are present and testosterone is unequivocally and consistently low. It also recommends confirming the finding with a repeat morning fasting measurement. That wording matters because many symptoms blamed on testosterone overlap with depression, sleep apnoea, thyroid disease, medication effects, alcohol use, overtraining, and ordinary life stress.
If low testosterone is confirmed, the next question is why. Primary hypogonadism points towards testicular dysfunction. Secondary hypogonadism points towards the pituitary or hypothalamus, or to reversible suppression from illness, energy deficit, obesity, or some medicines. Luteinising hormone, follicle-stimulating hormone, prolactin, thyroid markers, iron studies, and medication review may be relevant depending on the clinical picture. That is why this is not a home-diagnosis project.
Ageing is real, but it is not the only signal
Average testosterone levels tend to fall gradually across adult life. The decline is usually modest, and the spread between individuals is wide. Some men in later life have levels well within the laboratory reference range; some younger men have low levels because of obesity, chronic disease, pituitary disorders, anabolic-steroid suppression, or other causes. Age changes the baseline probability, not the whole explanation.
A 2017 clinical perspective indexed on PubMed describes functional hypogonadism in middle-aged and older men as a potentially reversible state without recognised intrinsic structural disease of the reproductive axis. Organic hypogonadism usually reflects a clearer pathology in the hypothalamic-pituitary-testicular axis. Functional hypogonadism is more often linked with non-gonadal factors such as obesity, type 2 diabetes, chronic disease, and ageing. The distinction is important because functional suppression may improve when the underlying driver improves, whereas organic hypogonadism often needs specialist management.
That does not mean lifestyle reliably restores testosterone for every man. It means lifestyle belongs in the first conversation when the low result sits alongside poor sleep, abdominal obesity, insulin resistance, heavy alcohol intake, or low physical activity. It also means the goal should be broader than chasing one hormone. Better cardiometabolic health, strength, sleep, and mood are worthwhile even if the lab number barely moves.
Weight, insulin resistance, and the reversible pattern
The clearest lifestyle-linked pattern is metabolic. Visceral fat, insulin resistance, and type 2 diabetes are repeatedly associated with lower testosterone, and the relationship can run in both directions. Lower testosterone may make body composition harder to manage; increased adiposity and inflammation can also suppress the reproductive hormone axis.
A review on functional hypogonadism in obesity, diabetes, and metabolic syndrome describes this as a multifactorial and bidirectional relationship. It frames correct diagnosis and treatment of the underlying condition as central, with lifestyle changes considered first-line for functional cases. That is a cautious, useful framing. It does not promise that fat loss will normalise testosterone in everyone, but it supports the idea that metabolic health is often where the highest-yield work begins.
For a reader, the practical implication is not to crash diet. Severe energy restriction, rapid weight loss, and inadequate protein can produce their own hormonal stress. The more defensible approach is steady fat loss where appropriate, enough dietary protein to support lean mass, resistance training, and medical support for diabetes, sleep apnoea, or obesity when those conditions are present. Men using GLP-1 medicines, bariatric surgery pathways, or other medical weight-loss treatments should discuss fertility, muscle retention, nutrition, and testosterone testing with their clinician rather than treating the hormone as a separate project.
Exercise helps health more reliably than testosterone
Strength training is often sold as a testosterone intervention. The more careful reading is that exercise is a health intervention that may, in some circumstances, change testosterone. Those are not the same claim.
A systematic review and meta-analysis in Frontiers in Physiology found that short-term exercise training had inconsistent effects on basal testosterone in older men. Resistance training did not significantly change basal testosterone when studies were pooled, whilst aerobic and interval training showed small increases. The authors also noted that exercise can improve physiology even when testosterone does not rise.
That is the sensible takeaway. Resistance training can improve strength, muscle mass, insulin sensitivity, bone loading, confidence, and function. Aerobic training can improve cardiovascular fitness and metabolic risk. Those effects matter whether or not a morning testosterone result changes. Men who are new to lifting, have cardiovascular disease, uncontrolled blood pressure, hernia symptoms, severe joint pain, or a history of fainting with exertion should get appropriate guidance before starting hard training.
Sleep is plausible, but the evidence is uneven
Testosterone production is tied to sleep biology, so it is tempting to make sleep the master lever. The evidence is more uneven. Very short experimental sleep restriction can affect hormonal patterns, but not every controlled study finds a meaningful drop in testosterone, and many studies are small.
In two randomised controlled sleep-restriction studies in healthy young men, summarised on PubMed, acute and chronic short sleep did not significantly reduce plasma testosterone compared with habitual sleep. That does not make sleep irrelevant. Poor sleep can worsen appetite regulation, insulin sensitivity, mood, training recovery, erectile function, and daytime energy. Obstructive sleep apnoea is also common in men with obesity and fatigue, and it can mimic or aggravate low-testosterone symptoms.
The cautious advice is therefore to treat sleep as a foundation for health, not as a guaranteed testosterone lever. Loud snoring, witnessed pauses in breathing, morning headaches, high blood pressure, severe daytime sleepiness, or waking unrefreshed despite enough time in bed are reasons to seek assessment for sleep apnoea. Testosterone therapy can be inappropriate in untreated severe obstructive sleep apnoea, so this is not a side issue.
Supplements deserve particular scepticism
The testosterone supplement market is much louder than the evidence. Vitamin D, zinc, magnesium, ashwagandha, fenugreek, tongkat ali, D-aspartic acid, and multi-ingredient products are commonly marketed to men who feel tired or underperforming. Some small trials show changes in selected groups. Many products have weak evidence, inconsistent dosing, or quality-control problems.
The first distinction is deficiency versus enhancement. Replacing a documented nutrient deficiency is different from taking a product to push testosterone above a normal baseline. Zinc deficiency can impair reproductive function, but extra zinc in a replete person is not benign; high intakes can cause copper deficiency and gastrointestinal effects. Vitamin D testing and replacement may be reasonable when deficiency risk is high, but it should not be treated as testosterone therapy by another name.
Men should be especially cautious with products that imply steroid-like effects, contain proprietary blends, or are sold alongside dramatic before-and-after claims. Anyone with prostate cancer, breast cancer, infertility concerns, kidney disease, liver disease, bipolar disorder, anticoagulant use, or multiple prescriptions should check with a qualified clinician or pharmacist before using hormone-adjacent supplements.
What this means in practice
- If symptoms persist, ask for a properly timed morning testosterone test and repeat confirmation rather than interpreting one isolated result.
- Discuss low results in context: libido, erections, fertility plans, medication use, sleep, alcohol, body composition, diabetes risk, and thyroid symptoms all matter.
- Use resistance and aerobic training for strength, metabolic health, and function; treat any testosterone change as a possible side effect, not the main proof of success.
- If obesity, insulin resistance, or type 2 diabetes is part of the picture, prioritise medically supported metabolic care rather than extreme dieting.
- Screen for sleep apnoea symptoms before blaming low energy on testosterone alone, especially with loud snoring, high blood pressure, or daytime sleepiness.
- Be wary of testosterone-boosting supplements unless there is a documented deficiency or a clinician has reviewed the risks.
What we don’t know
We still do not have a clean lifestyle formula that reliably raises testosterone in all ageing men. Trials differ in age, baseline health, body composition, sleep status, exercise dose, assay method, and whether men were truly hypogonadal at the start. A change in total testosterone may also reflect shifts in sex hormone-binding globulin rather than a simple increase in biologically active hormone.
There is also a clinical uncertainty around functional hypogonadism. Some men improve when weight, sleep, medication burden, or chronic disease is addressed. Others remain symptomatic with repeatedly low measurements and need specialist assessment. Testosterone therapy can help carefully selected men, but it is not suitable for men trying to conceive in the near term and may be inappropriate with prostate or breast cancer, high haematocrit, untreated severe sleep apnoea, uncontrolled heart failure, recent heart attack or stroke, or thrombophilia, as the Endocrine Society guideline notes.
The conservative conclusion is not that lifestyle is powerless. It is that lifestyle is most credible when framed as support for the whole system: sleep, metabolic health, muscle, cardiovascular fitness, and careful diagnosis. Testosterone is one part of that picture, not the only measure of whether a man is ageing well.
Photo: Rodrigo Rodrigues | WOLF Λ R T on Unsplash.